Today's Date: March 28, 2024
Guo Guangchang: "Focus on building sustainable, predictable and enterprise with stable profit growth "   •   SunCoke Energy, Inc. Issues 2023 Sustainability Report   •   PRIVATE SCHOOL VILLAGE (PSV) AWARDS INAUGURAL ELEMENTARY-SCHOOL SCHOLARSHIPS   •   Mark Cuban Backs Overplay, the No-Code Game Creation Platform, Following Shark Tank Appearance   •   Lenzing strives to drive beneficial transformation across the value chain   •   Lightshift Energy Raises $100 Million From Greenbacker Capital Management to Expand Utility Scale Battery Storage Across North A   •   Cadence OTC Announces Community Investment Campaign to Support the Movement for Accessible Birth Control in Post-Roe America   •   Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report   •   ¡BUENA! 'LOTERÍA FANTÁSTICA' BRINGS THE FIESTA WITH WORLDWINNER'S FIRST-EVER BILINGUAL GAME   •   Chris Diehl Returns to 101 Mobility as Director of National Accounts   •   CYNTHIA BAILEY PARTNERS WITH KINDRA TO RAISE AWARENESS ABOUT VAGINAL HEALTH DURING MENOPAUSE   •   Apogee Enterprises Schedules Fourth Quarter Fiscal Year 2024 Earnings Release and Conference Call   •   Fox Lake Grade School District 114 Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources   •   The Home Depot Announces Agreement to Acquire SRS Distribution, a Leading Specialty Trade Distributor Across Multiple Verticals;   •   United Makes It Easier for Customers Who Use Wheelchairs to Book Flights That Can Accommodate Their Personal Device   •   Cardinal Tobin Blesses New Open-Air Mausoleum of the Holy Spirit Site   •   Sprinklr Appoints Amitabh Misra as Chief Technology Officer   •   Leidos Partnership deploys electronic health record system to joint DOD-VA federal health care site   •   Avnos and Deep Sky Forge Path to Gigaton-Scale Carbon Removal in Canada   •   SolarEdge Launches SolarEdge ONE Optimization Solution for Homeowners with a Dynamic Rate Plan in the Netherlands
Bookmark and Share

Geron to Host Virtual Investor Event on June 14, 2023

FOSTER CITY, Calif. , June 06 /Businesswire/ - Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, will host a virtual investor event on Wednesday, June 14, 2023 at 8:00 a.m. Eastern Time.

Topics to be covered at the event include:

  • Summary of new IMerge Phase 3 data in lower risk myelodysplastic syndromes (MDS) featured in 2023 medical meetings. This includes presentation of data at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2023 and upcoming presentations at the European Hematology Association (EHA) Annual Meeting taking place from June 8-11, 2023.
  • Overview of imetelstat clinical pipeline, including ongoing trials in myelofibrosis and acute myeloid leukemia.
  • Commercial view on lower risk MDS market opportunity for imetelstat.

Joining Geron’s management team during the presentation and live question and answer session are physician key opinion leaders and investigators of Geron clinical trials:

  • Uwe Platzbecker, M.D., Director, Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology, University Hospital, Leipzig, Germany
  • Rami S. Komrokji, M.D., Vice Chair of the Malignant Hematology Department at the Moffitt Cancer Center, Tampa, Florida

A live webcast of the event and related presentation will be available on the Company’s website at www.geron.com/investors/events. An archive of the webcast will be available on the Company’s website for 30 days.

About Geron

Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit http://www.geron.com/or follow us on LinkedIn.


STORY TAGS: Conference, Webcast, California, Biotechnology, FDA, Other Health, Health, Pharmaceutical, Oncology, Other Science, Research, Hospitals, Science, Clinical Trials, United States, North America,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News